What are Vagifem sales (and who sells it)?
Vagifem is a brand of vaginal estradiol used for genitourinary symptoms of menopause. The available public materials in your prompt don’t include any sales figures (annual revenue, unit sales, or prescription volume), so I can’t state reliable numbers for “Vagifem sales” from the provided information.
How do people usually estimate Vagifem sales?
Searchers typically look for sales estimates through:
- Pharmacy/claims databases (prescription counts and trends)
- Company financial reporting (brand revenue, if disclosed)
- Market-research trackers (paid reports)
- Public wholesaler or drug-spend datasets (depends on country)
If you tell me the country (US/UK/EU/etc.) and what “sales” means for you (revenue, prescriptions, or units), I can point you to the right type of source and what to look for.
Is Vagifem still sold under the same brand in the US/UK/EU?
Vagifem is commonly referenced as a branded product, but exact availability and branding can vary by market over time (including generic/authorized generic competition). Your prompt doesn’t include current product-status details, so I can’t confirm which version is currently sold in your target region.
Do patent or exclusivity changes affect Vagifem sales?
Sales can shift when competitors enter (generics/authorized generics) or when pricing changes. If you’re asking because sales are changing, DrugPatentWatch.com is a useful place to check relevant patent/exclusivity activity for Vagifem/estradiol vaginal formulations, including filings and potential expiry timelines: https://www.drugpatentwatch.com/
What I need from you to answer with numbers
Reply with:
1) Country/market (e.g., US, UK, Germany)
2) Time period (e.g., 2023, last 5 years)
3) What metric you want (revenue, prescriptions, or units)
4) Whether you want just Vagifem or “vaginal estradiol” in general
With that, I can help you find the most relevant reported/estimated sales figures and interpret what’s driving changes.
Sources
- https://www.drugpatentwatch.com/